Judge: Pfizer ($PFE) ran afoul of competition law

A federal judge has ruled that Pfizer ($PFE) violated the California Unfair Competition Law by illegally promoting the Neurontin epilepsy drug. The finding stems from the same case in which a federal jury last March decided the drugmaker violated federal racketeering law for the same practices and must pay $142 million in damages. Report

Suggested Articles

After a major label expansion in December, Amarin's Vascepa is preparing a major boom in sales with its marketing team nearly scaled up.

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.

Data on Roche's Polivy aren't yet enough to win support from England's cost watchdogs, who rejected the medicine based on long-term…